Translation, cross-cultural adaptation, and validation of the Persian version of Everyday Memory Questionnaire-Revised (EMQ-R) in patients with multiple sclerosis.

IF 1.4 4区心理学 Q4 CLINICAL NEUROLOGY

Applied Neuropsychology-Adult Pub Date : 2025-05-01 Epub Date: 2023-05-08 DOI:10.1080/23279095.2023.2205592

Akram Ahmadi, Masoume Hajipour, Fatemeh Vojoudi, Fatemeh Haresabadi, Ali Mashhadi, Mohammad-Ali Nahayati, Toktam Maleki Shahmahmood

{"title":"Translation, cross-cultural adaptation, and validation of the Persian version of Everyday Memory Questionnaire-Revised (EMQ-R) in patients with multiple sclerosis.","authors":"Akram Ahmadi, Masoume Hajipour, Fatemeh Vojoudi, Fatemeh Haresabadi, Ali Mashhadi, Mohammad-Ali Nahayati, Toktam Maleki Shahmahmood","doi":"10.1080/23279095.2023.2205592","DOIUrl":null,"url":null,"abstract":"Purpose: The present research translated and validated the Persian version of the Everyday Memory Questionnaire-Revised (EMQ-R) in patients with multiple sclerosis (MS).Methods: A two-step study was performed in the current work. First, the scale was translated and culturally adopted to Persian. In the second step, the translated questionnaire was presented to 150 patients with MS and 50 individuals in the control group. Then, construct validity (factor analysis and clinical validity) and reliability measures (test-retest reliability and internal consistency) were computed for this questionnaire.Results: Patients with MS obtained higher scores in EMQ-R than the control group (p < .001). The findings of the Kaiser-Meyer-Olkin and Bartlett test approved the sampling adequacy for computing the factor analysis (p < .001). The accuracy of the three-dimensional structure was confirmed by confirmatory factor analysis (CFA). Findings of test-retest (ICC = .95, 95%CI .91-.98, p < .001) and internal consistency revealed a satisfactory value (α = .95, p < .001).Conclusions: Satisfactory findings for construct validity and high values for reliability revealed that the Persian version of EMQ-R is a reliable and valid scale to measure the everyday memory of patients with MS in the cognitive assessments of this group.","PeriodicalId":51308,"journal":{"name":"Applied Neuropsychology-Adult","volume":" ","pages":"703-711"},"PeriodicalIF":1.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Neuropsychology-Adult","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/23279095.2023.2205592","RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/8 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: The present research translated and validated the Persian version of the Everyday Memory Questionnaire-Revised (EMQ-R) in patients with multiple sclerosis (MS).

Methods: A two-step study was performed in the current work. First, the scale was translated and culturally adopted to Persian. In the second step, the translated questionnaire was presented to 150 patients with MS and 50 individuals in the control group. Then, construct validity (factor analysis and clinical validity) and reliability measures (test-retest reliability and internal consistency) were computed for this questionnaire.

Results: Patients with MS obtained higher scores in EMQ-R than the control group (p < .001). The findings of the Kaiser-Meyer-Olkin and Bartlett test approved the sampling adequacy for computing the factor analysis (p < .001). The accuracy of the three-dimensional structure was confirmed by confirmatory factor analysis (CFA). Findings of test-retest (ICC = .95, 95%CI .91-.98, p < .001) and internal consistency revealed a satisfactory value (α = .95, p < .001).

Conclusions: Satisfactory findings for construct validity and high values for reliability revealed that the Persian version of EMQ-R is a reliable and valid scale to measure the everyday memory of patients with MS in the cognitive assessments of this group.

查看原文本刊更多论文

多发性硬化症患者每日记忆问卷(EMQ-R)波斯语版的翻译、跨文化适应和验证

目的:对多发性硬化症(MS)患者每日记忆问卷(EMQ-R)波斯语版进行翻译和验证。方法:本研究分为两步进行。首先，量表被翻译并在文化上被波斯语所接受。第二步，将翻译后的问卷分发给150名MS患者和50名对照组。然后计算本问卷的结构效度(因子分析和临床效度)和信度测度(重测信度和内部一致性)。结果:MS患者EMQ-R评分高于对照组(p .001)。Kaiser-Meyer-Olkin和Bartlett检验的结果证实了计算因子分析的抽样充分性(p .001)。验证性因子分析(CFA)证实了三维结构的准确性。测试-重测结果(ICC =。95, 95%ci .91。98, p .001)和内部一致性显示令人满意的值(α =。95, p .001)。结论:波斯语版EMQ-R量表具有良好的构念效度和较高的信度值，是一种可靠有效的MS患者日常记忆评估量表。波斯EMQ-R是一种有效、可靠、快速、易于管理的工具，用于评估患有多发性硬化症或其他临床疾病的患者对其认知功能障碍的信念和见解，在日常生活中有一些记忆和注意力困难的区分。该问卷可以作为评估认知缺陷的实用临床工具，这可能无法通过正式的神经心理学评估来检测，并且可以作为衡量治疗方法的效果的有价值的量表，以提高记忆功能，这种方法可以推广到日常生活表现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Applied Neuropsychology-Adult CLINICAL NEUROLOGY-PSYCHOLOGY

CiteScore

4.50

自引率

11.80%

发文量

134

期刊介绍： pplied Neuropsychology-Adult publishes clinical neuropsychological articles concerning assessment, brain functioning and neuroimaging, neuropsychological treatment, and rehabilitation in adults. Full-length articles and brief communications are included. Case studies of adult patients carefully assessing the nature, course, or treatment of clinical neuropsychological dysfunctions in the context of scientific literature, are suitable. Review manuscripts addressing critical issues are encouraged. Preference is given to papers of clinical relevance to others in the field. All submitted manuscripts are subject to initial appraisal by the Editor-in-Chief, and, if found suitable for further considerations are peer reviewed by independent, anonymous expert referees. All peer review is single-blind and submission is online via ScholarOne Manuscripts.